Glufosfamide With of Without Hydration in Treating Patients With Advanced Non-small Cell Lung Cancer

NCT00005055 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

39

Enrollment

NETWORK

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: glufosfamide

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC